DE60110421D1 - Implantierbare zusammensetzungen enthaltend niedermoleculare zellulosederivate - Google Patents

Implantierbare zusammensetzungen enthaltend niedermoleculare zellulosederivate

Info

Publication number
DE60110421D1
DE60110421D1 DE60110421T DE60110421T DE60110421D1 DE 60110421 D1 DE60110421 D1 DE 60110421D1 DE 60110421 T DE60110421 T DE 60110421T DE 60110421 T DE60110421 T DE 60110421T DE 60110421 D1 DE60110421 D1 DE 60110421D1
Authority
DE
Germany
Prior art keywords
low molecular
cellulose derivatives
compositions contained
contained low
implantable compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60110421T
Other languages
English (en)
Other versions
DE60110421T2 (de
Inventor
W Burns
Robert J Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of DE60110421D1 publication Critical patent/DE60110421D1/de
Publication of DE60110421T2 publication Critical patent/DE60110421T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
DE60110421T 2000-06-09 2001-06-07 Implantierbare zusammensetzungen enthaltend niedermoleculare zellulosederivate Expired - Lifetime DE60110421T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59137300A 2000-06-09 2000-06-09
US591373 2000-06-09
PCT/US2001/018592 WO2001095875A1 (en) 2000-06-09 2001-06-07 Low molecular weight polymeric compositions

Publications (2)

Publication Number Publication Date
DE60110421D1 true DE60110421D1 (de) 2005-06-02
DE60110421T2 DE60110421T2 (de) 2006-02-02

Family

ID=24366237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60110421T Expired - Lifetime DE60110421T2 (de) 2000-06-09 2001-06-07 Implantierbare zusammensetzungen enthaltend niedermoleculare zellulosederivate

Country Status (8)

Country Link
EP (1) EP1299083B1 (de)
JP (1) JP2004503483A (de)
AT (1) ATE293955T1 (de)
AU (1) AU2001275400A1 (de)
CA (1) CA2409431A1 (de)
DE (1) DE60110421T2 (de)
IL (1) IL153000A0 (de)
WO (1) WO2001095875A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20040918A1 (it) * 2004-12-29 2005-03-29 Luigi Ambrosio Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
US8932622B2 (en) * 2008-06-03 2015-01-13 Actamax Surgical Materials, Llc Tissue coating for preventing undesired tissue-to-tissue adhesions
US9254332B2 (en) 2013-03-15 2016-02-09 Arecor Limited Stable aqueous formulations of adenovirus vectors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IN192791B (de) * 1996-06-28 2004-05-22 Johnson & Johnson Medical

Also Published As

Publication number Publication date
DE60110421T2 (de) 2006-02-02
WO2001095875A1 (en) 2001-12-20
IL153000A0 (en) 2003-06-24
EP1299083B1 (de) 2005-04-27
EP1299083A1 (de) 2003-04-09
JP2004503483A (ja) 2004-02-05
CA2409431A1 (en) 2001-12-20
AU2001275400A1 (en) 2001-12-24
ATE293955T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
NZ501066A (en) Pharmaceutical formulations containing voriconazole and sulphobutylether beta-cyclodextrin
EP1143935A3 (de) Biokompatible augenimplantate mit gesteuerter wirkstofffreisetzung und die dazugehörigen verfahren
NZ527157A (en) Compositions for delivering bisphosphonates
AP1760A (en) Platinum derivative pharmaceutical formulations.
WO2007015739A3 (en) Pea-tempo/pea-bz coatings for controlled delivery of drugs from implantable medical devices
AU4319699A (en) Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
WO2006085908A3 (en) Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant
BR0015188A (pt) Composições farmacêuticas
MY167123A (en) Conveniently implantable sustained release drug compositions
AU2001231196A1 (en) Delivery of therapeutic biological from implantable tissue matrices
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
PT1256340E (pt) Sistema terapeutico transdermico aperfeicoado para o tratamento da doenca de parkinson
WO2002071953A3 (en) System for implanting an implant and method thereof
PT1076644E (pt) Aminotetralinas substituidas emn como ligandos para o receptor de neuropeptideoy y5 util no tratamento da obesidade e de outras perturbacoes
DE69808297T2 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
ZA200600027B (en) Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
ATE334633T1 (de) Zahnprothese mit wirkstoffabgabevorrichtung
PT998287E (pt) Utilizacao de levobupivacaina
DE60140318D1 (de) Konfiguration implantierter vorrichtungen
HK1089085A1 (en) Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
RS52011B (sr) Nova primena derivata taksoida
DE60110421D1 (de) Implantierbare zusammensetzungen enthaltend niedermoleculare zellulosederivate
SG152285A1 (en) Solid pharmaceutical formulation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition